N-((1S,2S)-2-Amino-1,2-diphenylethyl)-4-(trifluoromethyl)benzenesulfonamide, 97%, 1g

1-Methyl-cyclobutylamine hydrochloride, 95.0%, 5g

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 10g

2-(4-Formylphenoxy)propanenitrile, 95%, 5g

1-Phenylazetidin-2-one, 95%, 100mg

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 50mg

Methyl 4-(3-methoxy-3-oxopropyl)benzoate, 95.0%, 25g

4-Nitro-2,3-dihydro-1H-indene, 95.0%, 1g

[1-(4-bromophenyl)cyclopentyl]methanamine, 95%, 100mg

1-(3-Methoxyphenyl)-2-phenylethanol, 95.0%, 5g

2-bromo-4-(1-pyrrolidinylcarbonyl)pyridine, 95.0%, 1g

tert-Butyl ((2R,3R)-4-(4-acetamido-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate, 99%, 1g

2-Amino-6-methyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 5g